   
Piramal Pharma Limited 
CIN: L24297MH2020PLC338592 
Registered Office: Gr. Flr. Piramal Ananta, Agastya Corporate Park, Opp Fire Brigade, Kamani Junction, LBS Marg, Kurla (West), Mumbai – 400070 India 
T: +91 22 3802 3000 / 4000; Email: shareholders.ppl@piramal.com 
piramalpharma.com 
 
19th November, 2025   
  
BSE Limited     
P.J. Towers, Dalal Street, Fort, 
Mumbai- 400 001 
BSE scrip code: 543635 
National Stock Exchange of India Limited 
Exchange Plaza, Bandra-Kurla Complex, 
Bandra (East), Mumbai – 400 051 
NSE symbol: PPLPHARMA 
 
Sub: Intimation of Schedule of Analyst/ Institutional Investor Meetings under the 
SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 
 
Dear Sir / Madam, 
 
We wish to inform you that pursuant to Regulation 30(6) of the SEBI (Listing Obligations and 
Disclosure Requirements) Regulations, 2015, the schedule of Analyst /Institutional Investor 
Meetings with the Company is as under: 
 
Date Name of Analyst/Investor Meet Nature of Meeting Venue 
28th November, 
2025 
Citi India Pharma & Healthcare 
Tour 2025 
Group / One -on-one 
Meeting (In Person) 
Mumbai 
 
Note: Dates are subject to changes. Changes may happen du e to exigencies on the part of 
Investors / Company. 
 
Kindly take the above on record. 
 
Thanking you, 
 
Yours truly, 
For Piramal Pharma Limited 
 
 
 
Tanya Sanish 
Company Secretary 
